We report the identification of Ima, a novel Drosophila MAGUK-like protein, which contains two WW and four PDZ protein interaction domains and interacts with the small GTPase dRal in the yeast two-hybrid system and pull-down assays. The gene is expressed in distinct spatiotemporal patterns throughout embryonic development. Overexpression of Ima interferes with normal Drosophila development, indicating that the gene functions in a tissue specific manner. q
Introduction
Pattern formation during the development of all higher organisms rests on cell-cell communication systems. Many different kinds of receptors are expressed at the surface of cells to allow them to respond to signals provided by the environment (Freeman, 2000; Jamora and Fuchs, 2002) . Activation of these receptors leads to a large variety of biochemical events which are coordinated for example by scaffolding molecules like membrane-associated guanylate kinases (MAGUKs) (Dimitratos et al., 1999) to participate in the efficiency and specificity of signaling pathways (Anderson, 1996) . Ral (RalA and RalB) are Ras-like GTPases which cycle between GDP-or GTP-dependent conformations (Feig et al., 1996) . They participate in the control of cell differentiation (e.g. Goi et al., 1999) and proliferation (e.g. Miller et al., 1997) as well as cytoskeletal organization (Jullien-Flores et al., 1995) and vesicular transport (Moskalenko et al., 2002) . They can be activated by a variety of stimuli (e.g. Feig et al., 1996) and interact with various effector proteins including the Ral-binding protein (RalBP or RLIP) (Jullien-Flores et al., 1995) , the small GTPase Arf, phospholipase D (Jiang et al., 1995; Kim et al., 1998; Luo et al., 1998) and SEC5 (Moskalenko et al., 2002; Sugihara et al., 2002) . Here we report the identification of a novel Ral-interacting MAGUK-like Drosophila protein, termed Ima, which contains six protein-protein interaction domains including two WW and four PDZ domains as observed with the short protein variant of mammalian ARIP1 (Shoji, 2000) .
Results and discussion

Identification of Ima, a novel Ral-interacting protein of Drosophila
In order to identify novel mediators of Ral activity, we performed a yeast two-hybrid screen to isolate interacting partners of Drosophila Ral (dRal) from a cDNA expression library prepared from poly(A)
1 RNA of 0-21 h old embryos (see Section 3). As a bait, we employed a modified, constitutively active form of dRal, in which the amino acid residue glycine (G20) was replaced by valine (V20). In addition, the C-terminus of the molecule contained a serine residue (S198) in place of a cysteine residue (C198) to prevent geranyl geranylation-dependent membrane association of Ral. With the resulting RalG20VC198S protein we identified known Ral-interacting proteins such as dRalBP and a novel protein represented by a partial cDNA clone (Fig.  1A) . Sequences of this cDNA clone correspond to the annotated gene CG4117, located in position 57C2,3 on the right arm of the second chromosome (Flybase, 1999) . Transcripts of this gene are also represented by the full length expressed sequence tag (EST) clone LD27118 (Rubin et al., 2000) (Fig. 1B) .
In order to establish the genomic organization of the CG4117 transcription unit, we sequenced the full-length EST clone and compared it with the corresponding genomic DNA sequences (Adams et al., 2000) . Fig. 1B shows that the LD27118 transcription unit covers seven exons and six introns. The deduced polypeptide is 1202 amino acids in length with a calculated molecular weight of about 130 kDa. It contains two types of known protein-protein interaction domains composed of two WW domains and four PDZ (PSD-95 Discs Large Zonula-Occludens-1) domains, respectively ( Fig. 2A,B) . The protein exerts sequence similarity with previously characterized mammalian members of the membrane-associated guanylate kinases (MAGUK) family of proteins (Dimitratos et al., 1999) . Among these, the arrangement of the protein domains is most similar to those MAGUK family members which are characterized by an inverse arrangement of the protein interaction domains (Anderson, 1996) . These include ARIP1, MAGI-1 or the rat S-SCAM protein (Dobrosotskaya et al., 1997; Hirao et al., 1998; Shoji, 2000) ( Fig. 2A, B) . However, the protein lacks a typical guanylate kinase (GuK) domain as has only been observed for a short protein variant of ARIP1 among those proteins (Shoji, 2000) . Because of the similarity to inversely arranged MAGUK proteins we named the protein inversed MAGUK (Ima) which corresponds to the MAGI protein (GenBank No. NM_137707).
Mapping of the Ima and dRal interaction sites
In order to confirm a direct interaction between Ima and dRal, to examine whether the interaction requires the active form of dRal and to map the sites of interaction between the two proteins, we performed in vitro GST-pulldown assays (see Section 3). We used the constitutively active and dominant negative forms of dRal, termed G20V and S25N, respectively, containing the wildtype C-terminal sequence (for details see (Sawamoto et al., 1999a) ). These proteins were produced as GST-fusion proteins in E.coli and 35 S-labelled Ima full-length protein was generated by in vitro translation. The interaction between the two proteins is shown in Fig. 1C , indicating that it is independent of the activation status of dRal, since Ima binds to both the constitutively active RalG20V (Fig.  1C , lane 2) and the dominant negative RalS25N (Fig.  1C, lane 4) .
The partial Ima cDNA clone obtained in the yeast twohybrid screen coded for the PDZ domain 4 and most of PDZ domain 3 ( Fig. 2A) . To demonstrate the requirement of these domains for dRal-binding, we performed pulldown experiments with full-length GST-dRal and in vitro translated 35 S-labelled Ima which lacks the C-terminal PDZ domain (Fig. 1D) . The results in Fig. 1D indicate that Cterminally truncated Ima fails to bind dRal. The fourth PDZ domain is therefore necessary for the Ima interaction with dRal.
PDZ domains were shown to preferentially bind to small C-terminal peptide motifs of the sequence XS/ TXV or XS/TXL (Hung and Sheng, 2001; . The last four C-terminal amino acid residues of dRal comprise such a peptide motif of the sequence CTLL. We deleted these amino acids of dRal and asked whether the shortened protein is still able to associate with full length Ima. (Adams et al., 2000) and the gene structure of Ima as revealed by sequence comparison of the genomic region (Adams et al., 2000) with the full size cDNA LD27118. Note that the ima transcript covers the sequences of the two annotated genes CG15656 and CG4117 (Adams et al., 2000) . ( of the C-terminal CTLL motif of dRal no interaction was observed. In summary, these findings demonstrate that the fourth PDZ domain of Ima and the last four amino acid residues of dRal are necessary for the interaction of the two proteins.
Embryonic expression patterns of ima
In order to visualize the spatio-temporal distribution of ima transcripts in the organism, we performed in situ hybridizations on whole mount preparations of staged embryos using an antisense RNA probe prepared from ima cDNA.
ima transcripts are maternally expressed and remain ubiquitously distributed in the egg and early embryo (Fig.  3A) . During blastoderm formation, the amount of maternally provided mRNA decreases below the detection limit (data not shown). At the same stage, zygotic expression is initiated in two distinct domains of the embryo which are the dorsal side of the prospective trunc region and the posterior end of the embryo except for the germ line progenitors ('pole cells') (Fig. 3B) . During early gastrulation, transcripts decrease and vanish in the dorsal expression domain, whereas the posterior expression domain covers the posterior plate to which the pole cells are attached and follows the migration of the posterior midgut primordium (Fig. 3C ). During the stage at which the embryo reaches maximal germ band extension, mesodermal ima expression is initiated in a stripe pattern (Fig. 3D ) which during later stages of development becomes restricted to the visceral portion of the mesoderm (Fig. 3E, F) . These results indicate that ima is expressed in distinct spatial and temporal patterns during embryogenesis including the posterior terminal region of the embryo which is established under the control of torso receptor tyrosine kinase activity (St. Johnston and Nüsslein-Volhard, 1992 ).
Posterior ima expression is controlled by torso signaling
The finding that ima is expressed in the posterior terminal region of the embryo, which is established in response to torso-dependent Ras/Raf signaling (Lu et al., 1993) , prompted us to ask whether and how ima expression is controlled by the activity of this pathway. We examined ima expression in embryos which lack the activity of key components of the maternal terminal organizer system or its mediators such as the terminal gap genes tailless and huckebein . Embryos from females which were homozygous for the torso loss-of-function allele tor pm failed to express the posterior terminal ima expression domain (Fig. 3G) , whereas the dorsal expression domain of ima was not affected. This result shows that activated components of the torso signaling pathway are necessary for the activation of posterior terminal ima gene expression.
In order to place ima within the torso-dependent signaling cascade, we next asked whether ima is a direct control target of the maternal components of the pathway or whether its expression is regulated in response to their zygotic mediators, namely the zygotic gap genes tailless and huckebein . Posterior terminal expression was unchanged in embryos homozygous for the tailless loss-of-function allele tailless l10-22 (data not shown) but absent from embryos homozygous for a huckebein lossof-function allele (hkb 2 ; Fig. 3H ). Posterior terminal ima expression is not affected in homozygous hindsight mutant embryos, which lack a transcription factor that acts downstream and in response to huckebein activity (Yip et al., 1997 ) (data not shown). torso-dependent control of ima expression is therefore mediated by huckebein activity and represents a direct or indirect target of the huckebein encoded transcription factor (Brönner and Jäckle, 1996) and does not require hindsight activity.
Effects of altered Ima activities
In order to test whether lack of ima activity interferes, for example, with huckebein-dependent aspects of embryonic development, we examined homozygous embryos for the deletion Df(2R)CC2 which uncovers the genomic region 2R 57C2-57C5 as assessed by in situ hybridization to polytene salivary gland chromosomes (Boswell et al., 1991) . It deletes ima (2R 57C2,3) as well as several other genes (Flybase, 1999 ; own observation). Homozygous Df(2R)CC2 embryos develop no obvious body patterning defects but die in the egg shell (data not shown). These observations indicate that the lack of ima does not cause a scorable morphological defect.
We next performed ima gain-of-function experiments by employing the Gal4/UAS system (Brand and Perrimon, 1993) to examine the effect of a UAS-dependent Ima expression. Using the T80-Gal4 and daG32-Gal4 drivers, ima was ubiquitously expressed. In addition, we expressed ima in en-Gal4-driven stripes along the longitudinal axis of gastrulating embryos and by responding to the C155 elavGal4 driver in neurons (see Section 3). en stripe expression of ima had no scorable effect on development (data not shown), whereas ubiquitous and neural overexpression of Ima consistently caused a rough eye phenotype (Fig. 3J) and supernumerary, misoriented bristles on the notum (Fig. 3L) . None of these effects were observed when Ima deletion mutants lacking either the WW domains or the PDZ domains were expressed under otherwise identical conditions as full-size Ima (data not shown). Collectively, these observations indicate that misexpression of Ima interferes in a tissue-specific manner with normal Drosophila development and that this activity requires both the WW and the PDZ domains.
Experimental procedures
Yeast two-hybrid screen
For the yeast two-hybrid (YTH) screen (Fields and Song, 1989) , we used constitutively active Drosophila Ral (dRalG20V; (Sawamoto et al., 1999b) ) as a bait. In addition, the bait carried a mutation at position 198 of dRal (cysteine into serine) to prevent Ral-typical geranyl geranylation at the C-terminus and to thereby avoid interference with the nuclear YTH screen due to a possible membrane attachment of the bait molecule. The bait construct was obtained by PCR amplification using the dRalG20V sequences as template. The resulting BamHI/SmaI fragment was cloned into the Matchmaker III vector pGBKT7 (Clontech, Palo Alto, USA) and its identity was verified by DNA sequencing. Transformation of the bait construct into the yeast strain AH190 was performed according to the manufacturer (Clontech, Palo Alto, USA). Expression of the bait construct was verified by Western blot analysis with 0.5 mg/ml anti-BD antibody (Clontech, Palo Alto, USA) as primary antibody followed by AP-conjugated horse anti-mouse IgG (1:10000 dilution; Vector Laboratories, Burlingame, USA). No self-activation of the His3 reporter gene was noted after transformation of the yeast strain AH190 with the dRalG20V bait construct. As cDNA library we chose a library prepared from RNA of 0-21 h old Drosophila embryos (Clontech, Palo Alto, USA). Positive clones were identified by two nutritional selections and the b-galactosidase assay as outlined by the manufacturer (Clontech, Palo Alto, USA).
For b-galactosidase assays, 5 ml cultures of each positive candidate, the positive controls (pCL1-constitutive expression of b-galactosidase and p53/large T-Antigen) and the negative control (Lamin C/large T-Antigen) were grown over night in the appropriate selective medium. Based on OD 600 the same amount of cells was harvested by centrifugation (1000 £ g 5 0 ), applied on papers with the same diameter, subsequently lysed by two freeze/thaw cycles in liquid nitrogen and incubated for 6h in buffer Z (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , pH 7.0) with b-mercaptoethanol and b-Gal added as outlined by the manufacturer (Clontech, Palo Alto, USA).
Drosophila genetics, transgene construction and transformation
Flies were kept under standard conditions as described (Forjanic et al., 1997) . A detailed description of the balancer chromosomes and the mutations can be found in FLYBASE (Flybase, 1999) . The following mutants have been used: tor pm (Casanova and Struhl, 1989) , tll l10-22 (Frasch and Levine, 1987) , hkb 2 (Casanova, 1990) , hnt XE81 (Frank and Rushlow, 1996) and w 1118 (Hazelrigg et al., 1984) . Targeted misexpression was accomplished using the GAL4/UAS-system (Brand and Perrimon, 1993) with the following Gal4-driver lines: T80-Gal4 (Wilder and Perrimon, 1995) , elav-Gal4 (Lin and Goodman, 1994) , daG32-Gal4 (Wodarz et al., 1995) and en-GAL4 (Tabata et al., 1995) .
For generating the UAS-Ima-, UAS-ImaDWW-FLAGand UAS-ImaDPDZ-FLAG-fly lines, the respective coding region was amplified by PCR using the EST-clone LD27118 (Rubin et al., 2000) as template and EcoRI/XhoI cloned into the pUAST vector. The following primers (oligonucleotide sequences are described in 5 0 to 3 0 direction) have been
The resulting pUAST constructs were confirmed by sequencing on both strands and used for transformation of flies as described (Rubin and Spradling, 1982) . For each experiment outlined in the text, results have been confirmed using two independent transgenic lines.
Recombinant proteins
Proteins were either expressed as GST fusion proteins in E.coli or in vitro translated. Respective coding regions of Ima were amplified by PCR using the EST-clone LD27118 as template (Rubin et al., 2000) and cloned into the pcDNA3.1His vector for in vitro translations (Invitrogen, Karlsruhe, Germany). For dRal, the coding regions of dRalG20V and dRalS25N were amplified by PCR and the corresponding DNA fragments were cloned into the pGEX4T3 vector to obtain GST fusion constructs (Amersham Biosciences, Freiburg, Germany). The following primers were used:
0 SmaI dRalD198-201-GST: TTTTCCCGGGCTACT-TAAGTCTCCGCTTCTTGCATCTATC.
Expression of recombinant proteins and GST-pulldown assay
Chemical competent Escherichia coli BL21Codon Plus DE3 (Stratagene, La Jolla, USA) were transformed with the respective plasmid. Growth of the bacteria and expression of the recombinant proteins was carried out using standard protocols. For purification the pellet was resuspended in lysis buffer (25 mM Hepes-KOH pH 7.6; 0.1 mM EDTA pH 8.0; 12.5 mM MgCl 2 ; 10% Glycerol (HEMG) with 500 mM NaCl and 0.1% Nonidet NP-40) in the presence of protease inhibitors (EDTA free Complete Protease inhibitors, Roche, Mannheim, Germany). After 30 min incubation with lysozyme (0.01 g/ml) at 48C and a freeze-thaw step, cells were disrupted using a sonifier. After centrifugation (10,000 £ g 30 0 ), the supernatant was used for purification. The GST-fusion proteins were purified using Glutathione Sepharose 4B (Amersham Biosciences, Freiburg, Germany) according to the manufacturer's instructions.
In vitro transcriptions/translations were carried out using the TNT T7 Quick Coupled Transcription/Translation System (PROMEGA, Mannheim, Germany) according to the manufacturer's instructions. Proteins were labeled using the Pro Mix 35 S methionine/cysteine in vitro celllabeling-mix (Amersham Biosciences, Freiburg, Germany).
Fifty ml of the GST purified bait proteins were equilibrated with HEMG containing 100 mM NaCl and 0.01% Nonidet NP-40, mixed with 50 ml of 1:5 diluted in vitro translation reaction and incubated at 48C with constant rolling for 3 h. After extensive washing with HEMG including increasing NaCl/Nonidet NP-40 concentrations the samples were analysed using SDS-PAGE followed by fluorography using Amplify solution (Amersham Biosciences, Freiburg, Germany) and X-Omat films (Kodak, Stuttgart, Germany). The amount of bait input was adjusted using either Coomassie brilliant blue or GelCode (Pierce, Bonn, Germany) staining.
RNA in situ hybridization
Drosophila embryos were fixed and permeabilized as described (Tautz and Pfeifle, 1989) . In situ hybridizations were performed using digoxygenin (DIG, Roche, Mannheim, Germany) labeled probes with a hybridization temperature of 558C. Probes were detected by alkaline phosphatase-coupled anti-DIG antibodies (Roche, Mannheim, Germany) and NBT/BCIP (Roche, Mannheim, Germany) staining. Images were taken on a Zeiss Axiophot. and the Max Planck Society for support. Work was also supported by the Deutsche Forschungsgemeinschaft (SFB 271).
